Statistics
Publications
5
Citations
85
H-Index
5
Active since
1981
Affiliations
Morgan Stanley (United States)(Current)
Spiegel Rj is an author at Morgan Stanley (United States) specializing in interferon alfa therapy, interferon responses, and interferon-based therapy.
Publications per year
1981–1988
5
5
Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide.
Krigel Rl, Slywotzky Cm, Mathew Lonberg et al. · PubMed · 1988 · 23 citations
Interferon-alpha: current status and future promise.
Bonnem Em, Spiegel Rj · PubMed · 1984 · 21 citations
Fatal hepatic necrosis after high-dose chemotherapy following haloalkane anesthesia.
Spiegel Rj, Pizzo Pa, Fantone Jc et al. · PubMed · 1981 · 20 citations
INTRON A (interferon alfa-2b): clinical overview.
Spiegel Rj · PubMed · 1985 · 11 citations
Minimal antigenicity of intron A in human recipients demonstrated by three analytical methods.
Jacobs Sj, Sullivan Lm, M Salfi et al. · PubMed · 1988 · 10 citations
Life Sciences, Immunology, Oncology +17
1–5 of 5